| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |